Home
>
National Drug Code (NDC)
>
ACZONE
ACZONE - 0023-3670-30 - (dapsone)
Drug Information of ACZONE
| Product NDC: | 0023-3670 |
| Proprietary Name: | ACZONE |
| Non Proprietary Name: | dapsone |
| Active Ingredient(s): | 50 mg/g & nbsp; dapsone |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | GEL |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ACZONE
| Product NDC: | 0023-3670 |
| Labeler Name: | Allergan, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021794 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20090624 |
Package Information of ACZONE
| Package NDC: | 0023-3670-30 |
| Package Description: | 1 TUBE in 1 CARTON (0023-3670-30) > 30 g in 1 TUBE |
NDC Information of ACZONE
| NDC Code | 0023-3670-30 |
| Proprietary Name | ACZONE |
| Package Description | 1 TUBE in 1 CARTON (0023-3670-30) > 30 g in 1 TUBE |
| Product NDC | 0023-3670 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | dapsone |
| Dosage Form Name | GEL |
| Route Name | TOPICAL |
| Start Marketing Date | 20090624 |
| Marketing Category Name | NDA |
| Labeler Name | Allergan, Inc. |
| Substance Name | DAPSONE |
| Strength Number | 50 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | Sulfone [EPC],Sulfones [Chemical/Ingredient] |
